Skip to main content
Clinical Trials/NCT04261205
NCT04261205
Completed
Not Applicable

Evaluation of the Efficacy and Tolerance of Plasmapheresis by Double Cascade Filtration in a University Centre

Centre Hospitalier Universitaire de Nīmes1 site in 1 country70 target enrollmentAugust 4, 2018
ConditionsKidney Failure

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Kidney Failure
Sponsor
Centre Hospitalier Universitaire de Nīmes
Enrollment
70
Locations
1
Primary Endpoint
Apheresis by DFPP and biological efficiency
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

A study is being carried out to evaluate the biological, technical and clinical/biological efficacy of this technique, the practice of which is standardized in the department, in order to evaluate our practices and to improve them if necessary. As part of this study, the investigators will ask all patients scheduled for this procedure to participate in this observational prospective study without changing usual practices.

Detailed Description

The objective of the study is to conduct a prospective evaluation of the practice of apheresis by Double Filtration System Cascade system in a university centre in current practice with evaluation of the technical and biological effectiveness as the main objective and clinical and biological tolerance as the secondary objective for all consecutive sessions performed in a university centre over a period of 1 year.

Registry
clinicaltrials.gov
Start Date
August 4, 2018
End Date
November 13, 2020
Last Updated
5 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
Centre Hospitalier Universitaire de Nīmes
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Over 18 years of age I indication for plasmapheresis and hospitalized at Chu de Nimes.

Exclusion Criteria

  • Under guardianship or curatorship Refusal to participate

Outcomes

Primary Outcomes

Apheresis by DFPP and biological efficiency

Time Frame: over a period of one year

quantification of the purification carried out (volume)

Secondary Outcomes

  • variation of Hb, platelet and albumin before and after session(within 1 hour of all session)
  • Biological side effects(within 1 hour of all session)
  • Clinical side effects(within 1 hour of all session)

Study Sites (1)

Loading locations...

Similar Trials